Mid pregnancy perinatal and neonatal reproductive endocrinology A prospective cohort study in twins and singleton control subjects

Monday, November 30, 2015
Twin children are not overexposed to sex steroids at the time of birth, despite higher concentrations in their mothers. Opposite-sex twin girls do not show androgenic influence from their male co-twins. Boys of an opposite-sex twin have lower LH concentrations compared with same-sex dizygotic twin boys.

Read More

Antimullerian hormone levels decrease in female to male transsexual women using testosterone as cross sex therapy

Wednesday, April 29, 2015
Polycystic ovary syndrome is associated with elevated antimullerian hormone (AMH) levels. In this study, AMH serum levels significantly decreased after androgenic treatment in female-to-male transsexual subjects.

Read More

Anabolic steroid induced hypogonadism Diagnosis and treatment

Wednesday, April 30, 2014
A profile of the user with anabolic steroid–induced hypogonadism is provided, and management strategies are proposed.

Read More

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria

Monday, March 31, 2014
Extraction chromatography–radioimmunoassay and liquid chromatography–tandem mass spectrometry measurements of testosterone have similar performance for differentiating polycystic ovary syndrome from controls; different cutoff values should be considered depending on the setting (e.g., clinical vs. general populations).

Read More

Ontogeny of the ovary in polycystic ovary syndrome

Friday, June 28, 2013
Ovarian hyperandrogenism, hyperinsulinemia from insulin resistance, and altered intrafollicular paracrine signaling influence ovarian morphology, follicle survival, and growth as well as oocyte development in women with polycystic ovary syndrome.

Read More

Hyperandrogenism during puberty in the development of polycystic ovary syndrome

Friday, June 28, 2013
Androgen secretion during pubertal development is a normal event. Polycystic ovary syndrome may be viewed as a maladaptation of this advantageous process.

Read More

Introduction Male rejuvenation what the reproductive specialist needs to know

Friday, May 31, 2013
Androgens and other hormones are commonly being used by men in attempts to achieve a variety of health benefits that are often referred to as “male rejuvenation.” This series of articles will prepare the reproductive specialist to deal with these patients and their presented problems.

Read More

Serum INSL3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low dose hCG A randomized controlled trial

Wednesday, January 2, 2013
Serum INSL3 correlates with intratesticular testosterone during hCG administration. Measurement of serum INSL3 may be a useful biomarker of intratesticular testosterone during hCG treatment of infertile men.

Read More

Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns

Thursday, May 31, 2012
In mothers with polycystic ovary syndrome, metformin had no impact on antim€ullerian hormone or androgen levels but increased the free testosterone index in the umbilical vein of boys.

Read More

Translate »